[1]
|
D. E. Townsend, N. Ashdown, S. Bolton, J. Bradley, G. Duckworth, E. C. Moorhouse, et al., “The International Spread of Methicillin-Resistant Staphylococcus aureus,” Journal of Hospital Infection, Vol. 9, No. 1, 1987, pp. 60-71. doi:10.1016/0195-6701(87)90097-1
|
[2]
|
A. Voss, D. Milatovic, C. Wallrauch-Schwarz, V. T. Rosdahl and I. Braveny, “Methicillin-Resistant Staphylococcus aureus in Europe,” European Journal of Clinical Microbiology & Infectious Diseases, Vol. 13, No. 1, 1994, pp. 50-55. doi:10.1007/BF02026127
|
[3]
|
R. P. Wenzel, R. L. Thompson and S. M. Landry, “Hospital Acquired Infections in Intensive Care Unit Patients: An Overview with Emphasis on Epidemics,” American Journal of Infection Control, Vol. 4, No. 5, 1983, pp. 371-375.
|
[4]
|
J. D. Edgeworth, D. F. Treacher and S. J. Eykyn, “A 25-Year Study of Nosocomial Bacteremia in Adult Intensive Care Unit,” Critical Care Medicine, Vol. 27, No. 8, 1999, pp. 1421-1428. doi:10.1097/00003246-199908000-00002
|
[5]
|
J. L. Vincent, D. J. Bihari, P. M. Suter, et al., “The Prevalence of Nosocomial Infection in Intensive Care Units in Europe: Results of the European Prevalence of Infection in Intensive Care (EPIC) Study,” The Journal of the American Medical Association, Vol. 274, No. 8, 1995, pp. 639-644. doi:10.1001/jama.1995.03530080055041
|
[6]
|
R. P. Wenzel and M. B. Edmond, “The Impact of Hospital-Acquired Bloodstream Infections,” Emerging Infectious Disease, Vol. 7, No. 2, 2001, pp. 174-177.
doi:10.3201/eid0702.010203
|
[7]
|
J. E. Peacock Jr., F. J. Marsik and R. P. Wenzel, “Methicillin-Resistant Staphylococcus aureus: Introduction and Spread within a Hospital,” Annals of Internal Medicine, Vol. 93, No. 4, 1980, pp. 526-532.
|
[8]
|
J. M. Hughes, “Setting Priorities: Nationwide Nosocomial Infection Prevention and Control Programs in the USA,” European Journal of Clinical Microbiology & Infectious, Vol. 6, No. 3, 1987, pp. 348-351.
doi:10.1007/BF02017638
|
[9]
|
S. Al-Obeid, E. Collatz and L. Gutman, “Mechanism of Resistance to Vancomycin in Enterococcus faecium D366 and Enterococcus fecalis A256,” Antimicrobial Agents and Chemotherapy, Vol. 34, No. 2, 1990, pp. 252-256.
|
[10]
|
S. Salmenlinna, O. Lyytikainen and J. Vuopio-Varkila, “Community Acquired methicillin resistant Staphylococcus aureus, Finland,” Emerging Infectious Diseases, Vol. 18, No. 1, 2002, pp. 602-607.
|
[11]
|
World Health Organization, “Recommendations for the Control of Methicillin Resistant Staphylococcus aureus (MRSA),” WHO, Geneva, 1996.
|
[12]
|
E. Dickinson, “Mortality from Methicillin-Resistant Staphylococcus aureus in England and Wales: Analysis of Death Certificates,” British Medical Journal, Vol. 325, No. 7377, 2002, pp. 1390-1391.
doi:10.1136/bmj.325.7377.1390
|
[13]
|
L. Collier, A. Balows and M. Sussman, “Bacterial Infections. Topley and Wilson’s Microbiology and Microbial Infections,” 9th Edition, Arnold Publication, London, 1998, pp. 231-256.
|
[14]
|
B. N. Doebbeling, “The Epidemiology of Methicillin Resistant Staphylococcus aureus Colonization and Infection,” Journal of Chemotherapeutics, Vol. 7, Suppl. 3, 1995, pp. 99-103.
|
[15]
|
A. L. Panlilio, D. H. Culver, R. P. Gaynes, S. Banerjee, T. S. Henderson, J. S. Tolson, et al., “Methicillin-Resistant Staphylococcus aureus in US Hospitals, 1975-1991,” Infection Control and Hospital Epidemiology, Vol. 13, No. 10, 1992, pp. 582-586. doi:10.1086/646432
|
[16]
|
S. Verma, S. Joshi, V. Chitnis, N. Hemwani, D. Chitnis, “Growing Problem of Methicillin Resistant Staphylococci—Indian Scenario,” Indian Journal of Medical Sciences, Vol. 54, No. 12, 2000, pp. 535-540.
|
[17]
|
A. P. Mehta, C. Rodrigues, K. Sheth, S. Jani, A. Hakimiyar and N. Fazalbhoy, “Control of Methicillin Resistant Staphylococcus aureus in a Tertiary Care Centre: A Five Year Study,” Indian Journal of Medical Microbiology, Vol. 16, No. 1, 1998, pp. 31-34.
|
[18]
|
K. Hiramatsu, H. Hanaki and T. Ino, “Methicillin-Resistant Staphylococcus aureus Clinical Strain with Reduced Vancomycin Susceptibility,” Journal of Antimicrobial Chemotherapy, Vol. 40, No. 1, 1997, 135-136.
doi:10.1093/jac/40.1.135
|
[19]
|
J. E. Geraci, “Some Laboratory and Clinical Experiences with a New Antibiotic, Vancomycin,” In: Antibiotic Annual 1955-1956, Medical Encyclopedia, New York, 1956, pp. 90-106.
|
[20]
|
R. C. Moellering, “The Specter of Glycopeptide Resistance: Current Trends and Future Considerations,” American Journal of Medicine, Vol. 104, Suppl. 5A, 1998, pp. 3S-6S.
doi:10.1016/S0002-9343(98)00148-X
|
[21]
|
C. U. Tuazon and H. Miller, “Clinical and Microbiologic Aspects of Serious Infections Caused by Staphylococcus epidermidis,” Scandinavian Journal of Infectious Diseases, Vol. 15, No. 4, 1983, pp. 347-360.
|
[22]
|
C. G. Unakal and B. B. Kaliwal, “Vancomycin-Resistant Staphylococcus aureus Containing van A Gene Isolated from Clinical Samples of Community Health Care Centers of North Karnataka, India,” Proceedings of International Society BioTechnology Conference (ISBT-2008), Gangtok, 28-30 December 2008, pp. 464-468.
|
[23]
|
National Committee for Clinical Laboratory Standards, “Methods for Dilution a Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically: Approved Standard 2000, M7-A5,” 5th Edition, NCCLS, Wayne, 2000.
|
[24]
|
J. Valles, C. Leon and F. Alvarez-Lerma, “Nosocomial Bacteremia in Critically Ill Patients: A Multi-Center Study Evaluating Epidemiology and Prognosis,” Clinical Infectious Diseases, Vol. 24, No. 3, 1997, 24: pp. 387-395.
doi:10.1093/clinids/24.3.387
|
[25]
|
D. R. Schaberg, D. H. Culver and R. P. Gaynes, “Major Trends in the Microbial Etiology of Nosocomial Infection,” American Journal of Medicine, Vol. 91, Suppl. 3B, 1991, pp. 72-75. doi:10.1016/0002-9343(91)90346-Y
|
[26]
|
W. Sligl, G. Taylor and P. G. Brindley, “Five Years of Nosocomial Gram-Negative Bacteremia in a General Intensive Care Unit: Epidemiology, Antimicrobial Susceptibility Patterns, and Outcomes,” International Journal of Infectious Diseases, Vol. 10, No. 4, 2006, pp. 320-325.
doi:10.1016/j.ijid.2005.07.003
|
[27]
|
V. Suljagic, M. Cobeljic, S. Jancovic, V. Mirovic, L. Markovic-Denic, P. Romic and D. Mikic, “Nosocomial Bloodstream Infections in ICU and Non-ICU Patients,” American Journal of Infection Control, Vol. 33, No. 6, 2005, pp. 333-340. doi:10.1016/j.ajic.2005.03.010
|
[28]
|
T. N. Jang, B. I. Kuo, S. H. Shen, C. P. Fung, S. H. Lee, T. L. Yang and C. S. Huang, “Nosocomial Gram-Negative Bacteremia in Critically Ill Patients: Epidemiologic Characteristics and Prognostic Factors in 147 Episodes,” Journal of the Formosan Medical Association, No. 7, 1999, 98: pp. 465-473.
|
[29]
|
A. Colpan, E. Akinci, A. Erbay, N. Balaban and H. Bodur, “Evaluation of Risk Factors for Mortality in Intensive Care Units: A Prospective Study from a Referral Hospital in Turkey,” American Journal of Infection Control, Vol. 33, No. 1, 2005, pp. 42-47.
doi:10.1016/j.ajic.2004.09.005
|
[30]
|
K. B. Laupland, D. A. Zygun, C. J. Doig, S. M. Bagshaw, L. W. Svenson and G. H. Fick, “One-Year Mortality of Bloodstream Infection-Associated Sepsis and Septic Shock among patients Presenting to a Regional Critical Care System,” Intensive Care Medicine, Vol. 31, No. 2, 2005, pp. 213-219. doi:10.1007/s00134-004-2544-6
|
[31]
|
M. Arvanitidou, E. Katikaridou, J. Douboyas and A. Tsakris, “Prognostic Factors for Nosocomial Bacteraemia Outcome: A Prospective Study in a Greek Teaching Hospital,” Journal of Hospital Infection, Vol. 61, No. 3, 2005, pp. 219-324. doi:10.1016/j.jhin.2005.03.006
|
[32]
|
Y. C. Lin, T. L. Chen, H. L. Ju, H. S. Chen, F. D. Wang, K. W. Yu and C. Y. Liu, “Clinical Characteristics and Risk Factors for Attributable Mortality in Enterobacter cloacae Bacteremia,” Journal of Microbiology, Immunology and Infection, Vol. 39, No. 1, 2006, pp. 67-72.
|
[33]
|
A. Alborzi, B. A. Pourabbas, H. Salehi, B. H. Pourabbas, B. Oboodi and M. R. Panjehshahin, “Prevalence and Pattern of Antibiotic Sensitivity of Methicillin Sensitive and Resistant Staphylococcus aureus in Shiraz-Iran,” Iranian Journal of Medical Sciences, Vol. 25, 2000, pp. 1-8.
|
[34]
|
S. Vidhani, P. L. Mehndiratta and M. D. Mathur, “Study of Methicillin Resistant S. aureus (MRSA) Ilolates from High Risk Patients,” Indian Journal of Medical Microbiology, Vol. 19, 2001, pp. 13-16.
|
[35]
|
J. P. Arbuthnott, D. C. Coleman and J. S. DeAsavedo, “Staphylococcal Toxins in Human Disease,” Journal of Applied Bacteriology, Vol. 69, Suppl. 19, 1990, pp. 101S-107S. doi:10.1111/j.1365-2672.1990.tb01802.x
|
[36]
|
R. L. Thompson, I. Cabezuclo and R. P. Werizel, “Epidemiology of Nosocomial Infections Caused by Methicillin-Resistant Staphylococcus Aureus Infections Caused by Methicillin-Resistant Staphylococcus Aureus,” Annals of Internal Medicine, Vol. 97, No. 3, 1982, pp. 309-317.
|
[37]
|
J. R. Myers and C. C. Linnemann, “Bacteremia Due to Methicillin Resistant Staphylococcus aureus,” Journal of Infectious Diseases, Vol. 145, No. 4, 1982, pp. 532-536.
doi:10.1093/infdis/145.4.532
|
[38]
|
S. Nishijima, S. Namura, K. Mitsuya, et al., “The Incidence of Isolation of MRSA Strains from Skin Infections during 1989-1991,” Journal of Dermatology, Vol. 20, No. 4, 1993, pp. 193-197.
|
[39]
|
S. K. Mathur, S. Singhal, K. N. Prasad, et al., “Prevalence of Methicillin Resistant Staphylococcus aureus (MRSA) in a Tertiary Care Hospital,” Indian Journal of Medical Microbiology, Vol. 12, 1994, pp. 96-101.
|
[40]
|
K. G. Bhat and M. G. Bhat, “Prevalence of Nosocomial Infections Due to Methicillin Resistant Staphylococcus aureus in Mangalore, India,” Biomedicine, Vol. 17, No. 1, 1997, pp. 17-20.
|